Cirrhosis: Difference between revisions
Perobinson (talk | contribs) |
Perobinson (talk | contribs) |
||
Line 1: | Line 1: | ||
===Background=== | ===Background=== | ||
A generally irreversible fibrotic scaring of the liver parenchyma. | |||
===Differential=== | ===Differential=== |
Revision as of 17:40, 15 June 2016
Background
A generally irreversible fibrotic scaring of the liver parenchyma.
Differential
- Hepatitis chronic B and C
- Alcoholic liver disease
- Non-alcoholic steatohepatitis
- Drug induced (ie. Tylenol)
- Cardiac Cirrhosis
- Primary biliary cirrhosis
- Primary sclerosing cholangitis
- Autoimmune Hepatitis
- Alpha1 anti-trypsin Deficiency
- Cystic Fibrosis
Clinical Features
Child-Pugh Classification for Cirrhosis Mortality
+1 | +2 | +3 | |
---|---|---|---|
Bilirubin | <2 mg/dL | 2-3 mg/dL | >3 Mg/dL |
Albumin | >3.5 mg/dL | 2.8-3.5 mg/dL | <2.8 mg/dL |
INR | <1.7 | 1.7-2.2 | >2.2 |
Ascites | No ascites | Ascites, medically controlled | Ascites, poorly controlled |
Encephalopathy | No encephalopathy | Encephalopathy, medically controlled | Encephalopathy, poorly controlled |
- Score ≤ 7 = Class A = 100% and 85% one and two-year patient survival
- Score 7 - 9 = Class B = 80% and 60% one and two-year patient survival
- Score ≥ 10 = Class c = 45% and 35% one and two-year patient survival
MELD-Na Score (Model End Stage Liver Disease)
MELD-Na Score | 3-month mortality |
---|---|
40 | 71.3% |
30-39 | 52.6% |
20-29 | 19.6% |
10-19 | 6.0% |
<9 | 1.9% |